Prof. MD. Osman Hakan Leblebicioğlu

International Book Contributions

• Leblebicioglu H. Crimean-Congo hemorrhagic fever. In: Hirsch MA, ed. UpToDate. Waltham, MA: UpToDate; 2018.

• Rojek A, Carson G, Kato Y, Horby PW, Leblebicioglu H. Viral Hemorrhagic Fevers. In: Cohen J, Powderly WG, Opal SM (eds). Infectious Diseases. 4th Ed. Elsevier, 2017: 1110–1118.e2.

• Leblebicioglu H. Crimean-Congo hemorrhagic fever. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J (eds). Harrison’s Principles of Internal Medicine Updates, 19th Ed. McGraw Hill Education, New York; 2017.

• Pshenichnaya N, Chulanov V, Leblebicioglu H. Epidemiology of Hepatitis B. In: Ozaras R, Tahan V (eds). Viral Hepatitis: Chronic Hepatitis B. Springer, Cham; 2018.

• Chulanov V, Pshenichnaya N, Leblebicioglu H. Genetic Diversity of the Hepatitis B Virus and Its Epidemiological Significance. In: Ozaras R, Tahan V (eds). Viral Hepatitis: Chronic Hepatitis B. Springer, Cham; 2018.

• Ozaras R, Leblebicioglu H. Global Epidemiology of Hepatitis C Virus Infection. In: Ozaras R, Salmon-Ceron D (eds). Viral Hepatitis: Chronic Hepatitis C. Springer, Cham; 2019.

International Publications

• Full publication list:
  • Scopus Profile: http://www.scopus.com/authid/detail.uri?origin=resultslist&authorId=24073322700&zone=
  • Publons Profile: https://publons.com/researcher/2321282/hakan-leblebicioglu/

Selected Publications (2017–2020)

• Pshenichnaya NY, Leblebicioglu H, Bozkurt I, et al. Crimean-Congo hemorrhagic fever in pregnancy: A systematic review and case series from Russia, Kazakhstan, and Turkey. International Journal of Infectious Diseases. 2017; 58:58–64.

• Al-Abri SS, Abaidani IA, Fazlalipour M, Mostafavi E, Leblebicioglu H, et al. Current status of Crimean-Congo haemorrhagic fever in the WHO Eastern Mediterranean Region: Issues, challenges, and future directions. International Journal of Infectious Diseases. 2017; 58:82–89.

• Bozkurt I, Coksevim M, Cevik BI, Gulel O, Tanyel E, Leblebicioglu H. Infective endocarditis with atypical clinical feature and relapse by Abiotrophia defectiva: Case report. Journal of the Saudi Heart Association. 2017; 29(2):136–138.

• Leblebicioglu H, Ozaras R, Sunbul M. Crimean-Congo Hemorrhagic Fever: A neglected infectious disease with potential nosocomial infection threat. American Journal of Infection Control. 2017; 45(1):815–816.

• Fletcher TE, Gulzhan A, Ahmeti S, Al-Abri SS, Asik Z, Atilla A, Beeching NJ, Bilek H, Bozkurt I, Christova I, Duygu F, Esen S, Khanna A, Kader C, Mardani M, Mahmood F, Mamuchishvili N, Pshenichnaya N, Sunbul M, Yalcin TY, Leblebicioglu H. Infection prevention and control practice for Crimean-Congo hemorrhagic fever – A multi-center cross-sectional survey in Eurasia. PLoS One. 2017; 12(9): e0182315.

• Sunbul M, Cerik H, Cerik B, Gulel O, Leblebicioglu H. A fatal case of Enterococcus durans endocarditis and literature review. American Journal of Therapeutics. 2018; 25:e663–e665.

• Leblebicioglu H, Arends JE, Ozaras R, Corti G, Santos L, Boesecke C, et al. Availability of hepatitis C diagnostics and therapeutics in European and Eurasian countries. Antiviral Research. 2018; 150:9–14.

• Faria LC, Terrabuio DRB, Leblebicioglu H, Huprikar S. Viral hepatitis recommendations for solid-organ transplant recipients and donors. Transplantation. 2018; 102(2S Suppl 2):S66–S71.

• Clemente WT, Pierrotti LC, Abdala E, Morris MI, López-Vélez R, Cuenca-Estrella M, Torre-Cisneros J, Petersen E, Camargo LFA, Wright AJ, Beeching NJ, Vilela EG, Santoro-Lopes G, Len O, Stucchi RSB, Manuel O, Faria LC, Leblebicioglu H, et al. Recommendations for management of endemic diseases and travel medicine in solid-organ transplant recipients and donors: Latin America. Transplantation. 2018; 102(2):193–208.

• Leblebicioglu H, Ozaras R. Hepatitis E virus infection in Turkey: A systematic review. Annals of Clinical Microbiology and Antimicrobials. 2018; 17(1):17.

• Fletcher TE, Leblebicioglu H, Bozkurt I, et al. Rotational thromboelastometry alongside conventional coagulation testing in patients with Crimean-Congo hemorrhagic fever: An observational cohort study. The Lancet Infectious Diseases. 2019; 8:862–871.

• Sharun K, Dhama K, Patel SK, Pathak M, Tiwari R, Singh BR, Sah R, Bonilla-Aldana DK, Rodriguez-Morales AJ, Leblebicioglu H. Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19. Annals of Clinical Microbiology and Antimicrobials. 2020; 19(1):23.